Wikidata

(Q27852594)

English

HER2 in high-risk rectal cancer patients treated in EXPERT-C, a randomized phase II trial of neoadjuvant capecitabine and oxaliplatin (CAPOX) and chemoradiotherapy (CRT) with or without cetuximab

scientific article

In more languages
default for all languages
No label defined

No description defined

Statements

title
HER2 in high-risk rectal cancer patients treated in EXPERT-C, a randomized phase II trial of neoadjuvant capecitabine and oxaliplatin (CAPOX) and chemoradiotherapy (CRT) with or without cetuximab (English)
1 reference
stated in
PubMed
PubMed publication ID
24146218
retrieved
13 November 2016
author name string
F Sclafani
series ordinal
1
0 references
A Roy
series ordinal
2
0 references
A Wotherspoon
series ordinal
4
0 references
C Peckitt
series ordinal
5
0 references
D Gonzalez de Castro
series ordinal
6
0 references
A Cervantes
series ordinal
9
0 references
Z Eltahir
series ordinal
10
0 references
J Oates
series ordinal
11
0 references
I Chau
series ordinal
12
0 references
publication date
December 2013
0 references
volume
24
0 references
issue
12
0 references
page(s)
3123-8
0 references

Identifiers

DOI
10.1093/ANNONC/MDT408
0 references
 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q27852594&oldid=1838665901"